Alkem Lab

{
  "main_header": {
    "sid": 1000019,
    "name": "Alkem Lab",
    "stock_name": "Alkem Lab",
    "full_name": "Alkem Laboratories Ltd",
    "name_url": "stocks-analysis/alkem-lab",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,425.00",
    "chg": -3.5,
    "chgp": "-0.06%",
    "dir": -1,
    "prev_price": "5,428.50",
    "mcapval": "65,345.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 539523,
    "symbol": "ALKEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE540L01014",
    "curr_date": "Jun 25, 03:30 PM",
    "curr_time": "11:07 AM",
    "last_traded_at": "Jun 25, 03:30 PM IST",
    "bse_nse_vol": "2.4 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 25, 2026",
    "traded_date_str": "2026 06 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-4073601",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_oi_spurts_by_underlying_4073601.png",
        "date": "2026-06-25 15:01:09",
        "description": "Alkem Laboratories Ltd has witnessed a significant 21.9% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock’s price showed a marginal decline of 0.07% on 25 Jun 2026, reflecting a complex interplay between bullish bets and profit-taking in the pharmaceuticals sector."
      },
      {
        "title": "Alkem Laboratories Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-significant-open-interest-surge-amid-mixed-market-signals-4073474",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_oi_spurts_by_underlying_4073474.png",
        "date": "2026-06-25 14:00:55",
        "description": "Alkem Laboratories Ltd has witnessed a notable 13.7% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest day change of -0.20%, the pharmaceutical mid-cap’s recent volume and delivery trends suggest a complex interplay of bullish and bearish bets as traders recalibrate ahead of upcoming catalysts."
      },
      {
        "title": "Alkem Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-sell-4072980",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_mojoScore_4072980.png",
        "date": "2026-06-25 10:11:35",
        "description": "Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 25 June 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing."
      },
      {
        "title": "Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-4072486",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_technicaldot_4072486.png",
        "date": "2026-06-25 08:04:06",
        "description": "Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a modest day gain of 0.37%, the stock’s mixed signals across MACD, RSI, moving averages, and other momentum oscillators suggest cautious optimism amid ongoing market volatility."
      },
      {
        "title": "Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4067906",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_valuationdot_4067906.png",
        "date": "2026-06-23 08:01:04",
        "description": "Alkem Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a modest day decline of 0.16%. This change reflects evolving market perceptions amid a competitive pharmaceutical sector, with key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios signalling enhanced price appeal relative to historical and peer benchmarks."
      },
      {
        "title": "Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4053406",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_valuationdot_4053406.png",
        "date": "2026-06-15 08:01:48",
        "description": "Alkem Laboratories Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive valuation grade amid evolving market dynamics. Despite a modest day change of -0.10%, the pharmaceutical mid-cap’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest a more compelling entry point relative to its historical averages and peer group, prompting a downgrade in its overall Mojo Grade to Sell from Hold as of 11 May 2026."
      },
      {
        "title": "Alkem Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-sell-4052747",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_mojoScore_4052747.png",
        "date": "2026-06-14 10:10:29",
        "description": "Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Alkem Laboratories Declines 4.48%: 3 Key Technical Shifts Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-declines-448-3-key-technical-shifts-shape-the-week-4052049",
        "imagepath": "",
        "date": "2026-06-13 16:20:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Significant open interest surge amid bearish price action</p>\n                    <p><strong>1 June:</strong> Technical momentum shifts to sideways with mixed signals</p>\n                    <p><strong>2 June:</strong> Mildly bearish technical shift amid market volatility</p>\n                    <p><strong>5 June:</strong> Week closes at Rs.5,251.25 (-4.48%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,497.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.5,2..."
      },
      {
        "title": "Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4037492",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_valuationdot_4037492.png",
        "date": "2026-06-08 08:01:51",
        "description": "Alkem Laboratories Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This change reflects evolving market perceptions and relative valuation improvements within the Pharmaceuticals & Biotechnology sector, offering investors a fresh perspective on the stock’s price attractiveness."
      }
    ],
    "total": 598,
    "sid": "1000019",
    "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019"
  },
  "announcements": [
    {
      "details": "Alkem Laboratories Limited has informed the Exchange regarding 'Intimation of Opening of Trading Window'.",
      "source": "NSE",
      "caption": "Alkem Laboratories Limited - Updates",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "Alkem Laboratories Limited has informed the Exchange regarding a press release dated November 01, 2019, titled \"Closure of US FDA Inspection at Alkem s manufacturing facility located at Daman, India and Baddi, India. \".",
      "source": "NSE",
      "caption": "Alkem Laboratories Limited - Press Release",
      "datetime": "01-Nov-2019"
    },
    {
      "details": "Alkem Laboratories Limited has informed the Exchange regarding a press release dated October 22, 2019, titled \"Update on US FDA Inspection at Alkem s Bioequivalence Center at Taloja\".",
      "source": "NSE",
      "caption": "Alkem Laboratories Limited - Press Release",
      "datetime": "22-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alkem Laboratories Ltd has declared <strong>2150%</strong> dividend, ex-date: 20 Feb 26",
          "dt": "2026-02-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-06-25 15:01:09

Alkem Laboratories Ltd has witnessed a significant 21.9% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock’s price showed a marginal decline of 0.07% on 25 Jun 2026, reflecting a complex interplay between bullish bets and profit-taking in the pharmaceuticals sector.

Read full news article

Alkem Laboratories Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-06-25 14:00:55

Alkem Laboratories Ltd has witnessed a notable 13.7% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest day change of -0.20%, the pharmaceutical mid-cap’s recent volume and delivery trends suggest a complex interplay of bullish and bearish bets as traders recalibrate ahead of upcoming catalysts.

Read full news article

Alkem Laboratories Ltd is Rated Sell

2026-06-25 10:11:35

Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 25 June 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing.

Read full news article

Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-25 08:04:06

Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a modest day gain of 0.37%, the stock’s mixed signals across MACD, RSI, moving averages, and other momentum oscillators suggest cautious optimism amid ongoing market volatility.

Read full news article

Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-06-23 08:01:04

Alkem Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a modest day decline of 0.16%. This change reflects evolving market perceptions amid a competitive pharmaceutical sector, with key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios signalling enhanced price appeal relative to historical and peer benchmarks.

Read full news article

Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-06-15 08:01:48

Alkem Laboratories Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive valuation grade amid evolving market dynamics. Despite a modest day change of -0.10%, the pharmaceutical mid-cap’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest a more compelling entry point relative to its historical averages and peer group, prompting a downgrade in its overall Mojo Grade to Sell from Hold as of 11 May 2026.

Read full news article

Alkem Laboratories Ltd is Rated Sell

2026-06-14 10:10:29

Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Alkem Laboratories Declines 4.48%: 3 Key Technical Shifts Shape the Week

2026-06-13 16:20:01

Key Events This Week

1 June: Significant open interest surge amid bearish price action

1 June: Technical momentum shifts to sideways with mixed signals

2 June: Mildly bearish technical shift amid market volatility

5 June: Week closes at Rs.5,251.25 (-4.48%)

Week Open

Rs.5,497.80

Week Close

Rs.5,2...

Read full news article

Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-06-08 08:01:51

Alkem Laboratories Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This change reflects evolving market perceptions and relative valuation improvements within the Pharmaceuticals & Biotechnology sector, offering investors a fresh perspective on the stock’s price attractiveness.

Read full news article

View All News